Comparing glycemic targets in overweight and obese women with gestational diabetes
Official title: Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Mellitus: A Multicenter Randomized Trial
Run by Indiana University · NCT05124808 · Data updated 2026-11-12
This study tests whether setting stricter blood sugar goals during pregnancy helps overweight and obese women with gestational diabetes have better outcomes for themselves and their babies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 828 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 5 sites (Birmingham, Alabama and 4 other locations) |
| Status | Recruiting |
| Started | March 1, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT05124808 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18-45 with a singleton gestation and diagnosed with gestational diabetes while being overweight or obese.
✕Probably not a fit
Patients with significant fetal anomalies or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized clinical trial involves 828 overweight and obese pregnant women diagnosed with gestational diabetes. The study aims to compare the effects of intensive glycemic targets against standard glycemic targets on perinatal outcomes. Participants will be monitored throughout their pregnancy to assess the impact of these glycemic control strategies on complications associated with gestational diabetes. The trial is conducted across four medical centers in the U.S. with high obesity rates, ensuring a diverse participant pool.
Why it matters
Potential benefit: If successful, this study could lead to improved pregnancy outcomes for overweight and obese women with gestational diabetes.
How similar studies have gone: Previous studies have shown promising results with intensive glycemic control in similar populations, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women between the ages of 18-45 * Singleton gestation * Gestational age between 12 0/7-32 6/7 weeks' gestation with gestational diabetes diagnosed during this time frame using either a 50g 1-hr GCT ≥200 mg/dL or two or more abnormal values on a 100g OGTT using the Carpenter-Coustan Criteria * Overweight or obese BMI at the first prenatal visit (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian Americans) Exclusion Criteria: * Inability or unwillingness to provide informed consent * Inability to communicate with members of the study team, despite the presence of an interpreter * Planned delivery at a non-study affiliated hospital * Known renal disease with a baseline creatinine \>1.5 mg/dL * Significant fetal anomalies diagnosed prior to study enrollment (these will include anomalies such as gastroschisis, spina bifida, complex congenital heart disease, or serious karyotypic anomalies that may lead to early delivery or increased risk of neonatal death) * Oral or IV/IM steroid use within 7 days of study enrollment
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting -
Indiana University
Indianapolis, Indiana, United States Recruiting -
University of Oklahoma
Norman, Oklahoma, United States Recruiting -
University of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States Recruiting
Study contacts
- Principal investigator: Christina Scifres, MD — Indiana University
- Study coordinator: Rasika Sadolikar, MBBS, MPH
- Email: rsadolik@iu.edu
- Phone: (317)278-8040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Randomized comparison of immediate in-hospital 2-hour OGTT versus standard 4–12 week postpartum 2-hour OGTT for people with gestational diabetes
This will test whether doing a 2-hour OGTT before hospital discharge gets more people who had gestational diabetes screened for diabetes than the usual 4–12 week outpatient test.
-
Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese
A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
MR-based performance tests for overweight and obesity
This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.